Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges.

Vecchiarelli A, Pericolini E, Gabrielli E, Pietrella D.

Front Microbiol. 2012 Aug 13;3:294. doi: 10.3389/fmicb.2012.00294. eCollection 2012.

2.
3.

Immunity to Candida.

Fidel PL Jr.

Oral Dis. 2002;8 Suppl 2:69-75. Review.

PMID:
12164664
4.

Distinct protective host defenses against oral and vaginal candidiasis.

Fidel PL Jr.

Med Mycol. 2002 Aug;40(4):359-75. Review.

PMID:
12230215
6.

Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candidal balanoposthitis in China.

Li J, Fan SR, Liu XP, Li DM, Nie ZH, Li F, Lin H, Huang WM, Zong LL, Jin JG, Lei H, Bai FY.

Clin Infect Dis. 2008 Nov 1;47(9):1119-25. doi: 10.1086/592249.

PMID:
18808351
7.

Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.

Cassone A.

BJOG. 2015 May;122(6):785-94. doi: 10.1111/1471-0528.12994. Epub 2014 Jul 23. Review.

8.

Protective antigens and mechanisms of anti-Candida immunity.

Antonio C.

Nihon Ishinkin Gakkai Zasshi. 2000;41(4):219. Review.

9.

Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.

Scarsini M, Tomasinsig L, Arzese A, D'Este F, Oro D, Skerlavaj B.

Peptides. 2015 Sep;71:211-21. doi: 10.1016/j.peptides.2015.07.023. Epub 2015 Jul 31.

PMID:
26238597
10.

Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.

Vicariotto F, Del Piano M, Mogna L, Mogna G.

J Clin Gastroenterol. 2012 Oct;46 Suppl:S73-80. doi: 10.1097/MCG.0b013e3182684d71.

PMID:
22955364
11.

History and update on host defense against vaginal candidiasis.

Fidel PL Jr.

Am J Reprod Immunol. 2007 Jan;57(1):2-12. Review.

PMID:
17156186
12.

NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.

Ibrahim AS, Luo G, Gebremariam T, Lee H, Schmidt CS, Hennessey JP Jr, French SW, Yeaman MR, Filler SG, Edwards JE Jr.

Vaccine. 2013 Nov 12;31(47):5549-56. doi: 10.1016/j.vaccine.2013.09.016. Epub 2013 Sep 21.

13.

Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.

Chew SY, Than LT.

Mycoses. 2016 May;59(5):262-73. doi: 10.1111/myc.12455. Epub 2016 Jan 13. Review.

PMID:
26765516
14.

Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders.

Cassone A, Cauda R.

AIDS. 2012 Jul 31;26(12):1457-72. doi: 10.1097/QAD.0b013e3283536ba8. Review.

PMID:
22472853
15.

Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.

Spellberg BJ, Ibrahim AS, Avanesian V, Fu Y, Myers C, Phan QT, Filler SG, Yeaman MR, Edwards JE Jr.

J Infect Dis. 2006 Jul 15;194(2):256-60. Epub 2006 Jun 6.

PMID:
16779733
16.

A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.

Sandini S, La Valle R, Deaglio S, Malavasi F, Cassone A, De Bernardis F.

FEMS Immunol Med Microbiol. 2011 Jul;62(2):215-24. doi: 10.1111/j.1574-695X.2011.00802.x. Epub 2011 Apr 28.

17.

A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis.

Thomas DP, Viudes A, Monteagudo C, Lazzell AL, Saville SP, López-Ribot JL.

Proteomics. 2006 Nov;6(22):6033-41.

PMID:
17051645
18.

Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G).

Cárdenas-Freytag L, Steele C, Wormley FL Jr, Cheng E, Clements JD, Fidel PL Jr.

Med Mycol. 2002 Jun;40(3):291-9.

PMID:
12146759
19.

Does vaginal douching affect the type of candidal vulvovaginal infection?

Shaaban OM, Abbas AM, Moharram AM, Farhan MM, Hassanen IH.

Med Mycol. 2015 Nov;53(8):817-27. doi: 10.1093/mmy/myv042. Epub 2015 Jun 30.

PMID:
26129887
20.

The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside.

Cole GT, Halawa AA, Anaissie EJ.

Clin Infect Dis. 1996 May;22 Suppl 2:S73-88. Review.

PMID:
8722833

Supplemental Content

Support Center